PainReform (PRFX) to Release Quarterly Earnings on Monday

PainReform (NASDAQ:PRFX) is anticipated to announce its earnings results before the market opens on Monday, March 17th. Analysts expect the company to announce earnings of ($4.74) per share for the quarter.

PainReform Trading Up 5.3 %

Shares of PainReform stock opened at $2.79 on Friday. The firm has a market capitalization of $2.44 million, a PE ratio of -0.02 and a beta of 0.61. PainReform has a twelve month low of $1.73 and a twelve month high of $61.20. The firm’s 50-day moving average price is $3.10 and its 200 day moving average price is $2.96.

About PainReform

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.